We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

Medicare Act Increases Risk of Declaratory Judgment Actions Against Innovators

30 April 2004

Pharmaceutical Law & Industry Report

Although not widely publicized, several provisions of the Medicare Prescription Drug, Modernization, and Improvement Act (the Medicare Act) may prove important to innovator pharmaceutical companies.


Loading data